Loading organizations...
§ Private Profile · Los Angeles, CA, USA
Medical technology company developing neuromodulation devices for patients with spinal cord injuries, focused on restoring motor function.
Founded in 2016 by Dr. Yi-Kai Lo and Dr. Wentai Liu, Aneuvo is a Los Angeles-based clinical-stage medical technology company developing non-invasive neuromodulation devices for patients with spinal cord injuries. The firm's flagship product, the wearable ExaStim Stimulation System, is utilized alongside physical rehabilitation to help restore lost motor function and improve overall patient strength. Operating with an estimated 10 to 50 employees, the enterprise has secured financial backing from investors such as Venture Codex to advance its proprietary neurotechnology. Led by an executive team that includes Chief Executive Officer Yi-Kai Lo and Vice President Katie Velez, the organization targets clinical rehabilitation centers and healthcare providers. The company has achieved key regulatory milestones, including Breakthrough Device Designation from the United States FDA and European CE Mark approval, while progressing through its ASPIRE multi-center clinical trials.
Aneuvo has raised $22.0M across 1 funding round.
Aneuvo has raised $22.0M in total across 1 funding round.
Aneuvo has raised $22.0M in total across 1 funding round.
Aneuvo's investors include Catcher Technology.
Aneuvo has raised $22.0M across 1 funding round. Most recently, it raised $22.0M Series C in March 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 26, 2026 | $22M Series C | Catcher Technology | — | Announced |